PSS-type B displays various clinical similarities with Netherton syndrome caused by genetic defects of serine protease inhibitor Kazal-type5 (SPINK5). (Wile, 1924; Traupe, 1989; Magert HJ et al, 1999; Chavanas et al, 2000) .
Human tissue kallikreins are a family of 15 trypsin-like or chymotrypsin-like secreted serine proteases (hK1-hK15) found in a variety of tissues (Yousef and Diamandis, 2001) . At least 8 different hKs have been identified in the stratum corneum & sweat as desquamation-related proteases (Komatsu et al, 2005b (Komatsu et al, , 2006 . hKs may contribute to the overall SC protease activities and the degradation of intercellular adhesion molecules resulting in desquamation of corneocytes (Simon et al, 2001; Komatsu et al, 2002; Caubet et al, 2004) . SPINK5 inhibitory domains are believed to be negative regulators of desquamation related proteases including hKs (Mitsudo et al, 2003; Descargues et al, 2005; Egelrud et al, 2005; Schechter et al, 2005) .
The gene(s) responsible for PSS pathogenesis, as well as the relationship between kallikrein (hK) expression and skin manifestations in PSS, have not as yet been determined. The reasons for the similarities between Netherton syndrome & PSStype B
, despite the intact SPINK5 in the latter, are still unknown.
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PSS-type B may not be an ichthyosis characterized by the retention of thick adherent scales, but an overdesquamation disease due to an over-expression of hKs and an elevation of the SC protease activities. The over-desquamation of corneocytes may explain the clinical similarities between PSS-type B & Netherton syndrome.
The elevated SC enzymatic activities may be good therapeutic targets for PSS-type B patients. SPINK5 has been proved to be intact, therefore, Netherton syndrome was ruled out, leaving PSS-type B as the most likely diagnosis.
Informed consent was obtained from all patients, their parents and normal volunteers, and our studies were performed according to the Declaration of Helsinki. The Medical Ethics Committee of the Graduate School of Medical Science, School of Medicine, Kanazawa University; and Juntendo University School of Medicine, approved all described studies.
Immunohistochemistry for hKs & SPINK5 proteins
In PSS-type B patients, hKs & SPINK5 protein expressions were deeply expanded into the lower epidermis compared with those in normal skin.
It was previously demonstrated that NS patients show absent or only faint staining in the skin epidermis when the same anti-SPINK5 protein Ab is applied (Raghunath et al, 2004) . 
Histopathology
HE staining. Skin sections were obtained from an erythematous & scaling lesion 1 month after birth for both patients.
The findings are: 1) absence of the SC or a few layers of parakeratosis, which tended to be separated from the stratum granulosum; 2) psoriasisforme acanthosis;
3) perivascular infiltration with mainly mononuclear leukocytes (a & c), and some eosinophils (d,▲). (Simon et al, 2001; Caubet et al, 2004; Descargues et al, 2005) .
(c) PSS-type B:
an unknown mechanism may lead to overexpression of multiple hKs. The production of SPINK5 proteins/domains could be elevated to inhibit hK activity.
However, overall SC protease activities may override SPINK5 domains' inhibitory function. The over-expression of hKs results in elevated SC protease activity, which is followed by overdegradation of the adhesion molecules and ultimately, over-desquamation of corneocytes. Since SPINK5 protein possesses anti-"plasmin" function (Mitsudo et al, 2003) , overall SC "plasmin-like (VLK-) activity" was predicted.
Substrate
Time Normal
PSS-type B
Released AMC or pNA 
Trypsin-like Activity
Phe-Ser-Arg-AMC 2 15.5 ± 1.5 21.0 15.5 Pro-Phe-Arg-AMC 2 5.7 ± 3.1 24.0 * 18.6 *
Chymotrypsin-like Activity
Arg-Pro-Tyr-pNA 4 13.9 ± 5.5 11.9 13.7
Furin-like Activity
Pyr-Arg-Thr-Lys-Arg-AMC 2 3.0 ± 1.3 43.0 * 28.5 *
Plasmin-like Activity
Val-Leu-Lys-AMC 2 1.7 ± 1.0 8.9 * 19.6 * SPINK5 pro-protein can be proteolytically processed at (R-KR↓) by furin-like activity to 15 individual bioactive domains (Seidah & Chretien, 1999; Komatsu et al, 2002; Mitsudo K et al, 2003) .
According to their kinetic properties, hK5, hK6, hK8, hK13 & hK14 strongly display trypsin-like (FSR-) activity. hK7 may be largely responsible for the chymotrypsin-like (RPY-) activity.
The identity of enzymes contributing to PFR-& VLK-activities in the skin is unknown.
Clinical similarities or differences between PSS-type B & Netherton syndrome are indicated in red or blue, respectively.
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